Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 80,151 | 50,132 | 35,407 | -11,224 | 17,124 |
| Depreciation Amortization | 31,121 | 25,727 | 29,845 | 25,370 | 15,643 |
| Income taxes - deferred | 8,890 | -391 | 14,367 | -887 | 8,625 |
| Accounts receivable | -13,356 | 11,739 | -28,037 | -1,114 | -3,333 |
| Accounts payable and accrued liabilities | 4,486 | -3,753 | 312 | -1,141 | -2,374 |
| Other Working Capital | -4,857 | 16,669 | -22,732 | -9,399 | -2,922 |
| Other Operating Activity | 17,331 | 33,536 | 42,136 | 32,163 | 4,805 |
| Operating Cash Flow | $123,766 | $133,659 | $71,298 | $33,768 | $37,568 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -31,832 | -36,387 | -36,406 | -15,565 | -11,091 |
| Net Acquisitions | -10,841 | -42,498 | -55,515 | 989 | -23,892 |
| Purchase Of Investment | -21,824 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 1,108 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | 815 |
| Investing Cash Flow | $-63,389 | $-78,885 | $-91,921 | $-14,576 | $-34,168 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 6,943 | 188,922 | 41,915 | N/A | 339,007 |
| Debt Repayment | -17,026 | -157,541 | -108,085 | -202,956 | -1,479 |
| Common Stock Issued | 3,976 | 2,136 | 118,954 | 235,964 | 102,993 |
| Dividend Paid | -1,902 | -1,470 | -729 | N/A | N/A |
| Other Financing Activity | -783 | -26,872 | -4,825 | -32,226 | -452,025 |
| Financing Cash Flow | $-8,792 | $5,175 | $47,230 | $782 | $-11,504 |
| Exchange Rate Effect | 8,237 | 4,289 | -1,465 | -1,855 | -1,697 |
| Beginning Cash Position | 122,509 | 58,271 | 33,129 | 15,010 | 24,811 |
| End Cash Position | 182,331 | 122,509 | 58,271 | 33,129 | 15,010 |
| Net Cash Flow | $59,822 | $64,238 | $25,142 | $18,119 | $-9,801 |
| Free Cash Flow | |||||
| Operating Cash Flow | 123,766 | 133,659 | 71,298 | 33,768 | 37,568 |
| Capital Expenditure | -32,704 | -37,543 | -36,406 | -15,565 | -12,951 |
| Free Cash Flow | 91,062 | 96,116 | 34,892 | 18,203 | 24,617 |